Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline
Ultrasonography 2019³â 38±Ç 2È£ p.125 ~ p.134
±èÁöÈÆ(Kim Ji-Hoon) - Seoul National University Hospital Department of Radiology
¹éÁ¤È¯(Baek Jung-Hwan) - University of Ulsan College of Medicine Asan Medical Center Department of Radiology
ÀÓÇö°æ(Lim Hyun-Kyung) - Soonchunhyang University College of Medicine Seoul Hospital Department of Radiology
³ªµ¿±Ô(Na Dong-Gyu) - Gangneung Asan Hospital Department of Radiology
Abstract
Radiofrequency ablation (RFA) is a new, minimally invasive modality that serves as an alternative to surgery in patients with thyroid tumors. The Task Force Committee of the Korean Society of Thyroid Radiology developed recommendations for the optimal use of RFA for thyroid tumors in 2012 and revised them in 2017. Herein, we review and summarize the 2017 thyroid RFA guideline and compare it with the 2012 thyroid RFA guideline.
Å°¿öµå
Thyroid, Ultrasonography, Radiofrequency ablation, Ethanol ablation, Thyroid nodule, Thyroid neoplasms
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
This review article summarized the 2017 guideline and discussed the major differences between the 2012 and 2017 guidelines.